PROLIFICA - West African Treatment Cohort for Hepatitis B
Prevention of Liver Fibrosis and Cancer in Africa. Observational Study of Screening, Assessment and Treatment for Chronic Hepatitis B Virus Infection
Sponsor: Cheikh Anta Diop University, Senegal
This observational or N/A phase trial investigates Hepatitis B, Chronic and Hepatocellular Carcinoma and is currently completed. Cheikh Anta Diop University, Senegal leads this study, which shows 14 recorded versions since 2011 — indicating substantial longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
-
Jan 2021 — Dec 2021 [monthly]
Completed
▶ Show 9 earlier versions
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Oct 2020 — Nov 2020 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Nov 2019 — Oct 2020 [monthly]
Active Not Recruiting
Status: Completed → Active Not Recruiting
-
Jul 2019 — Nov 2019 [monthly]
Completed
Status: Unknown Status → Completed
-
Jun 2018 — Jul 2019 [monthly]
Unknown Status
-
May 2018 — Jun 2018 [monthly]
Unknown Status
-
Apr 2018 — May 2018 [monthly]
Unknown Status
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Aug 2017 [monthly]
Unknown Status NA
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Cheikh Anta Diop University, Senegal
- Department of State for Health and Social Welfare, The Gambia
- Imperial College London
- Institut National de la Santé Et de la Recherche Médicale, France
- International Agency for Research on Cancer
- Medical Research Council Unit, The Gambia
- UFR Sante de Thies, Senegal
For direct contact, visit the study record on ClinicalTrials.gov .